In this webinar, Akhil Sud and Vijay Raghavan from Allergan/AbbVie's marketing sciences team join H2O.ai's Dr. Michael Proctor to explain why they moved their marketing mix modeling from traditional linear regression to a gradient boosting model with Shapley value attribution. They cover the core limitations of regression-based attribution, including its assumptions about linear response curves, ad-stock decay, and channel interactions, and share validation tests and client results showing where the GBM-plus-Shapley approach outperforms. The discussion also covers practical caveats: no model fully accounts for unexpected market events, and results still need to hold up against business judgment.